ImmuPharma(DE:25I)
€0.01+0.00 (+40.00%)
DE:25I
ImmuPharma earnings date
€0.01
At close:+0.00 (+40.00%)
ImmuPharma (25I) Q2 2026 Earnings Report
0 Followers
DE:25I Q2 2026 EPS Results
- Actual EPS
- -EUR 0.01
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- EUR 0.00
DE:25I Q2 2026 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 09/15/2026
- Time
- Before Open
- Conference Call
- Tuesday, September 15, 2026
DE:25I Upcoming Earnings
ImmuPharma's next earnings date is estimated for May 25, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:25I Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| May 25, 2027 | 2026 (Q4) | ―- | 0 | ― | ― |
| Sep 15, 2026 | 2026 (Q2) | ―-0.01 | 0 | -100.00% (-0.00) | |
| May 27, 2026 | 2025 (Q4) | ―0.00 | -0.01 | 100.00% (+0.01) | |
| Aug 06, 2025 | 2025 (Q2) | ―-0.00 | 0 | -300.00% (-0.00) | |
| May 19, 2025 | 2024 (Q4) | ―-0.01 | ― | ― | |
| Sep 09, 2024 | 2024 (Q2) | ―-0.00 | 0 | 50.00% (+0.00) | |
| Jun 05, 2024 | 2023 (Q4) | ―- | -0.01 | ― | |
| Aug 31, 2023 | 2023 (Q2) | ―-0.00 | -0.01 | 66.67% (+0.00) | |
| May 11, 2023 | 2022 (Q4) | ―-0.01 | -0.02 | 61.11% (+0.01) | |
| Sep 30, 2022 | 2022 (Q2) | ―-0.01 | -0.02 | 60.00% (+0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

